Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040

Annals of Oncology - Tập 30 - Trang v452-v453 - 2019
E. Cohen1, K. Harrington2, D. Soulières3, C. Le Tourneau4, L.F. Licitra5, B. Burtness6, T. Bal7, J. Juco7, D. Aurora-Garg7, L. Huang7, R.F. Swaby7, K. Emancipator7
1Medicine, Moores Cancer Center, UC San Diego Health, La Jolla, CA, USA
2Medical Oncology, The Institute of Cancer Research/The Royal Marsden NHS Foundation Trust National Institute of Health Research Biomedical Research Centre, London, UK
3Medical Oncology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada
4Department of Drug Development and Innovation, Institut Curie, Paris and Saint-Cloud, INSERM U900 Research Unit, Saint-Cloud, France
5Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy
6Therapeutic Radiology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA
7Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 30

v452-v453

Thông tin tác giả